End foreign freeloading — don’t import it
Since day one in office, President Trump has been eager to put America first—even when it has meant upending norms, upsetting political allies, and straining relationships abroad. This eagerness is worth applauding.
That’s why Trump’s desire to impose foreign price controls on medicines created by U.S. scientists is so disconcerting.
Today’s global drug market isn’t fair. American patients pay more for medicines than our global counterparts—and by doing so, we pay for most medical innovation, as well. In fact, about two in three new medicines are now invented in the United States.
We pay more for medicines because in other countries, government regulators impose strict price controls on brandname medicines and restrict access to the newest ones.
To read more please log in or subscribe to the digital edition. http://www.etypeservices.com/Bridgeport%20News-BladeID393/